Skip to main content
S.Biomedics Co., Ltd. logo

S.Biomedics Co., Ltd. — Investor Relations & Filings

Ticker · 304360 ISIN · KR7304360001 KO Professional, scientific and technical activities
Open in API
Filings indexed 137 across all filing types
Latest filing 2026-04-22 Major Shareholding Noti…
Country KR South Korea
Listing KO 304360

About S.Biomedics Co., Ltd.

https://www.sbiomedics.com/eng/

S.Biomedics Co., Ltd. is a company specializing in the research and development of cell therapies for regenerative medicine. Established in 2005, the company focuses on creating, manufacturing, and supplying stem cell-based therapeutic products. Its core activities involve leveraging data-driven biology to develop fundamental and safe treatments for various conditions, with a significant focus on neurodegenerative disorders such as Parkinson's disease. S.Biomedics is committed to advancing the field of stem cell therapy from initial research to clinical application.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a ‘주식등의 대량보유상황보고서(약식)’—a report required under Korea’s Capital Markets Act when shareholdings cross statutory thresholds. It details the number of shares held, changes in ownership, the reporting party’s identity, and transaction details. This matches the “Major Shareholding Notification” category (MRQ).
2026-04-22 Korean
증권발행결과(자율공시) (제3자배정-전환우선주)
Share Issue/Capital Change Classification · 1% confidence The document is a voluntary disclosure (자율공시) detailing the results of a securities issuance: type of security (convertible preferred shares), issuance method (third-party allotment), number of shares, amount raised, decision and payment dates, and listing status. This constitutes an announcement of a new share issue/capital change. Therefore, it fits the “Share Issue/Capital Change” category (SHA).
2026-04-22 Korean
증권발행결과(자율공시) (제7회차 CB)
Capital/Financing Update Classification · 1% confidence The document is a voluntary disclosure titled “증권 발행결과” (security issuance result) detailing the terms and amounts of the company’s 7th series private convertible bond issuance, including resolution date, issue amount (₩22.2 billion), and payment date. This is an announcement of a debt financing/capital structure change via convertible bond issuance. It does not merely state that a report is published, nor is it an earnings release or proxy statement. The content fits a Capital/Financing Update.
2026-04-22 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a detailed ‘‘주요사항보고서(유상증자결정)’’, i.e. a regulatory filing announcing and describing a paid-in capital increase (third-party allotment of new shares). It provides the exact share types, numbers, issue price, purposes of funds, allotment details, and conditions for conversion and options—all hallmarks of a share issue/capital change announcement. Hence it fits Share Issue/Capital Change (SHA).
2026-04-14 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a ‘주요사항보고서’ reporting the company’s decision to issue convertible bonds, including detailed terms (amount, conversion price, call/put options, funding use). This is not a full annual or interim report, nor a simple publication notice, but a financing transaction notice. The closest category is a Capital/Financing Update (CAP), covering new fundraising and capital structure changes.
2026-04-14 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a regulatory filing reporting the appointment, dismissal, or mid‐term resignation of an outside director ('사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고'). It details changes in board membership and provides background on the newly appointed outside director. This clearly fits the Board/Management Information category (MANG).
2026-03-31 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.